Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Advanced Diagnostic Tests Not Needed for Some Miscarriages

By HospiMedica staff writers
Posted on 05 Feb 2003
A study has found that more than 82% of miscarriages are chromosomally abnormal in women 35 or over, revealing that many second and third miscarriages are likely to be simply the result of chance. More...
Therefore, they do not merit a lengthy and expensive diagnostic workup.

Researchers analyzed the results of karyotyping tests to determine the chromosomal characteristics of cells in 517 tissue samples from miscarriages. Overall, 56% were found to have chromosomal abnormalities, with even higher rates when adjusted for maternal age. The researchers recommend that karyotyping tests be pursued regularly after a second miscarriage, with more advanced diagnostic tests ordered for both parents only when no genetic abnormality is found.

"Many second and third miscarriages are likely to be simply by chance alone,” noted W.Allen Hogge, M.D., professor of obstetrics, gynecology, and reproductive sciences at the University of Pittsburgh School of Medicine (PA, USA), who led the study. "Even an extensive workup will fail to find a recognizable cause in up to half of these cases.”




Related Links:
University of Pittsburgh School of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.